FOR IMMEDIATE RELEASE For more information: Richard Jefferys Michael Palm Basic Science, Vaccines & Cure Project Director Treatment Action Group [email protected] Nelson Vergel Program for Wellness Restoration [email protected] PRESS RELEASE HIV Activists Seek to Accelerate Development of Immune Enhancing Therapies for Immunologic Non-Responders. Dialogues with FDA, scientists and […]
The Die is Cast at the STARTDavid Alain Wohl, MD – The University of North Carolina at Chapel Hill —————————– “HIV medicine has transitioned from an oncological mode created to manage a progressive and complicated fatal disease to a model that more closely resembles a diabetes clinic, where lab metrics are used to plot a
Good News in Aging with HIV Read More »
Randomized controlled trial Lindboe JB, et al. Infect Dis (Lond). 2016 Nov-Dec. Authors Lindboe JB1, Langkilde A1, Eugen-Olsen J2, Hansen BR2,3, Haupt TH1, Petersen J1,4, Andersen O1,3. Author information 1a Optimed, Clinical Research Centre 056, Copenhagen University Hospital Hvidovre , Hvidovre , Denmark ; 2b Clinical Research Centre 056, Copenhagen University Hospital Hvidovre , Hvidovre
Low-dose growth hormone therapy reduces inflammation in HIV-infected patients Read More »
Ben Klein, a Senior Attorney from GLAD.org speaks about the new bill approved in the state of Massachusetts in Aug. 2016 that mandates several insurance carriers in that state to reimburse cost for HIV related lipodystrophy therapies and how activists can advocate for similar bills in other states. California is also trying to get a
New Bill Mandates Coverage of HIV Lipodystrophy Treatments Read More »
Antiretroviral treatment – where we are now / New HIV Drugs & Treatments from: https://www.natap.org/2017/CROI/croi_151.htm Joseph J. Eron MD Professor of Medicine University of North Carolina at Chapel Hill The CROI meeting in Seattle this year was again a terrific mix of basic, translational, clinical and epidemiological research. This year perhaps we are seeing more clinical
New HIV Medications Being Studied in 2017 Read More »
Nelson Vergel, author of Testosterone: A Man’s Guide (Amazon.com) and founder of ExcelMale.com and DiscountedLabs.com, talks about what he thinks are the most important 10 things that all men on testosterone replacement therapy should know to maximize benefits and minimize side-effects. For questions for Nelson, please register on ExcelMale.com and post them on the forum
Top Ten Testosterone Replacement Monitoring Tips Read More »
In 2006, Timothy Brown, an American living in Berlin, was on antiretroviral therapy with good viral suppression when he developed leukemia and required bone marrow transplants after other treatment failed. His doctor in Berlin, Gero Hütter, MD, had the idea to use bone marrow from a donor with a double CCR5-delta-32 mutation, meaning the stem
Why Has Only One Person Been Cured of HIV in 10 Years? Read More »
We are constantly reading headlines about the latest HIV cure. After years of being exposed to these inflamed news reports, we may get desensitized to the fact that there is actually progress being made in that field. Ever since Timothy Brown was proven to be cured, the search for a cure for HIV that is
How Researchers Are Now Trying to Cure More HIV+ People Read More »
As a nutrition and exercise expert, in this video I share what I’ve learned in the past 27 years of exercising to combat HIV-related body changes, fatigue and mental outlook with great exercise tips that will save everyone time and costly mistakes. You can also read my tips in this article.
Exercise Tips for Health, Lean Muscle and Reduced Fat Read More »
Dr Vincent Marconi talks about his study “Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults” which is currently looking for volunteers. For more information about the study or how to join it, call us at 206-744-8883 or email us at [email protected] https://clinicaltrials.gov/ct2/show/N… Dr Vincent Marconi received his MD at the Johns Hopkins
Reducing HIV-Related Inflammation: Safety Study of Ruxolitinib Read More »
In the United States, the rate for anal cancer in the general population is 1 case per 100,000 people; among HIV-negative men who have sex with men the rate increases to 35 cases per 100,000 people. For HIV-positive gay and bisexual men, the rate is estimated to be between 75 to 115 cases per 100,000
Everything You Need to Know About Anal Cancer Prevention and Treatment Read More »
Nelson Vergel from PowerUSA.org interviews Dr Steven Grinspoon from Harvard Medical School about what we know about HIV lipodystrophy associated fat accumulation. Dr Grinspoon covers potential causes and treatments. For more information please refer to the closing image at the end of the video. QUESTIONS FOR DR GRINSPOON’S INTERVIEW: 1. Please give our audience background
Abdominal Fat Accumulation in HIV: Interview with Dr Grinspoon Read More »
